Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LeadingBiotech Officially Announces Its New Ambassador Committee

The select group of experts will advise on overall strategy and pinpoint important trends--helping to better serve its community of senior-level leaders.


News provided by

LeadingBiotech

Nov 19, 2018, 12:45 ET

Share this article

Share toX

Share this article

Share toX


BOSTON, Nov. 19, 2018 /PRNewswire-PRWeb/ -- LeadingBiotech (formerly Boston Biotech Conferences), creator of exclusive peer-to-peer CEO meetings for the biotech community, announces its new Ambassador Committee.

The committee is part of the recently appointed leadership team at LeadingBiotech. Along with CEO, Wendy Nelson Ph.D., and Chairman Bob Buderi, this select group of experts will have an influential role by advising on overall strategy and pinpointing important trends—helping to better serve its community of senior-level leaders.

I’m excited to work with the LeadingBiotech team as they take the preeminent biotech conference series with a global reach to the next level.

Post this

Meet the LeadingBiotech Ambassador Committee:

Brian Gallagher Jr. Ph.D.
Partner, Abingworth
Gallagher has over 20 years of investing, business development, operational and R&D experience in both biotechnology and pharmaceutical companies. Prior to joining Abingworth in October, he was a Partner for SR One, the venture arm of GSK, for 8 years. Gallagher received his Ph.D. in Organic Chemistry from University of Michigan.

"I'm excited to work with the LeadingBiotech team as they take the preeminent biotech conference series with a global reach to the next level." – Brian Gallagher Jr. Ph.D.

Carol Gallagher Pharm.D.
Partner, New Enterprise Associates
Gallagher has nearly 30 years of experience in commercial, drug development, and business roles in both large and small biopharma companies. Prior to joining NEA in 2014, she spent several years as an independent board director. From 2008-2011, she was CEO of Calistoga Pharmaceuticals which was acquired by Gilead. Gallagher received her Doctor of Pharmacy from the University of Kentucky.

Michael Gilman Ph.D.
Chairman and CEO, Arrakis Therapeutics
Gilman has made over 30 years of contributions in the biotech and biopharma fields. Prior to joining Arrakis Therapeutics in 2016, he was Founder and Chief Executive of Padlock Therapeutics, a venture-funded company focused on autoimmune disease. Gilman received his S.B. in Life Sciences from Massachusetts Institute of Technology and his Ph.D. in Biochemistry from University of California, Berkeley.

Rachel Haurwitz Ph.D.
President & CEO, Caribou Biosciences
Haurwitz is the co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. She has a research background in CRISPR-Cas biology and is also a co-founder of Intellia Therapeutics. Haurwitz received her A.B. in Biological Sciences from Harvard College and her Ph.D. in Molecular and Cell Biology from Universtiy of California, Berkeley.

Mary Lynne Hedley Ph.D.
President & Chief Operating Officer, TESARO
Hedley has over 20 years of experience in the biotech and biopharma fields. Prior to being co-founder of TESARO in 2010, she served as Executive Vice President of Operations and Chief Scientific Officer of Abraxis BioScience. Hedley completed two consecutive postdoctoral fellowships at Harvard University and received her B.S. in Microbiology from Purdue University and her Ph.D. in Immunology from University of Texas, Southwestern Medical Center.

Susan Windham-Bannister Ph.D.
President & CEO, Biomedical Growth Strategies LLC
Windham-Bannister has spent over 40 years advising major biopharma companies on strategic decisions essential for market access, growth optimization, and portfolio management. Prior to joining Biomedical Growth Strategies LLC in 2015, she served as founding President and CEO of the $1 billion Massachusetts Life Sciences Initiative. Windham-Bannister received her B.A. from Wellesley College, her Ph.D. in Health Policy and Management from Florence Heller School at Brandeis University, and her Sc.D. from Worcester Polytechnic Institute.

The Ambassador Committee is working with Nelson and Buderi to implement several exciting changes—making LeadingBiotech a premier networking and content-rich event series. "I'm thrilled to have the support and advice of such an esteemed group of Ambassadors as we work to bring our new brand LeadingBiotech forward!" – Wendy Nelson Ph.D.

Join us at the inaugural LeadingBiotech event, East/West CEO, to engage with some of the Ambassadors and other senior-level peers! The event is on January 5-6, 2019 at the Four Seasons Hotel in San Francisco, CA. Learn more.

Contact:
LeadingBiotech
Suzanne Carroll
[email protected]
+1 857-504-6707

SOURCE LeadingBiotech

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.